|
Re: In regards to the share price and trading...
|
2
|
Resverlogix Corp.
|
Mar 19, 2021 12:04PM
|
|
Re: In regards to the share price and trading...
|
2
|
Resverlogix Corp.
|
Mar 19, 2021 11:25AM
|
|
Re: In regards to the share price and trading...
|
3
|
Resverlogix Corp.
|
Mar 19, 2021 10:48AM
|
|
Re: In regards to the share price and trading...
|
4
|
Resverlogix Corp.
|
Mar 19, 2021 10:26AM
|
|
Re: is it a possibility we see r v x sell
|
1
|
Resverlogix Corp.
|
Mar 18, 2021 06:18PM
|
|
Re: is it a possibility we see r v x sell
|
2
|
Resverlogix Corp.
|
Mar 18, 2021 04:37PM
|
|
is it a possibility we see r v x sell
|
2
|
Resverlogix Corp.
|
Mar 18, 2021 04:14PM
|
|
Re: The cardiac pre-print now published....in Cell!
|
5
|
Resverlogix Corp.
|
Mar 16, 2021 05:30PM
|
|
Re: A few thoughts
|
2
|
Resverlogix Corp.
|
Mar 15, 2021 02:58PM
|
|
Re: Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
|
3
|
Zenith Epigenetics
|
Mar 15, 2021 01:57PM
|
|
Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral
|
5
|
Resverlogix Corp.
|
Mar 15, 2021 10:44AM
|
|
Re: Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
|
3
|
Zenith Epigenetics
|
Mar 15, 2021 10:22AM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
4
|
Resverlogix Corp.
|
Mar 14, 2021 07:16PM
|
|
if your thinking 3 months out for a rv or zen deal, think again...
|
3
|
Resverlogix Corp.
|
Mar 14, 2021 05:50PM
|
|
Re: ZHCLF
|
3
|
Zenith Epigenetics
|
Mar 14, 2021 03:07PM
|
|
Re: RVX's place in therapy - future prediction
|
2
|
Resverlogix Corp.
|
Mar 14, 2021 02:35PM
|
|
Re: ZHCLF
|
2
|
Zenith Epigenetics
|
Mar 14, 2021 01:31PM
|
|
Re: ZHCLF
|
2
|
Zenith Epigenetics
|
Mar 14, 2021 01:12PM
|
|
Re: Pharmacological Modulation of BET Family in Sepsis
|
1
|
Resverlogix Corp.
|
Mar 11, 2021 01:34PM
|
|
Re: Pharmacological Modulation of BET Family in Sepsis
|
2
|
Resverlogix Corp.
|
Mar 11, 2021 01:04PM
|
